Accentia Biopharms’s Reorganization Plans 0
The Tampa based Accentia Biopharmaceuticals Inc has declared its emergence from bankruptcy and has filed for reorganization of its debts. The filing of this plan has is in the interest of all the stakeholders.
This plan will make the company’s finances stronger and the balance sheet more favorable to serve long term liability obligations. This is also very important move in terms of protecting the liquidation of the company’s shares among more stake holders which will cause the instability of the company further. This plan is also in the works to restart the discovery of the Revimmune, which is an auto immune disease therapy system being developed by Accentia biopharmaceuticals and has the potential to increase the value of the company in the market. Accentia Biopharmaceuticals owns a huge part in the stocks of the Biovest International Inc which also works on immune therapies for single individuals. Biovest also has filed for emergence from bankruptcy and the reorganization is going on.
subscribe to comments RSS
There are no comments for this post